Clinical Trials Browser

Phase 2/3 × Recruiting × Immune Checkpoint Inhibitors × Clear all

NCT06958432 2025-08-07

Node-Sparing Short-Course Radiotherapy Sequential Chemotherapy and PD-1 Inhibitor for Mid/Low pMMR/MSS Rectal Cancer (MODIFI-RC-II)

Phase 2/3 Recruiting

Gastrointestinal

Rectal Neoplasms